South Korea
· Delayed Price · Currency is KRW Biolog Device Statistics
Total Valuation
Biolog Device has a market cap or net worth of KRW 30.78 billion. The enterprise value is 31.33 billion.
| Market Cap | 30.78B |
| Enterprise Value | 31.33B |
Important Dates
The next estimated earnings date is Thursday, November 14, 2024.
| Earnings Date | Nov 14, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
Biolog Device has 65.90 million shares outstanding. The number of shares has increased by 34.94% in one year.
| Shares Outstanding | 65.90M |
| Shares Change (YoY) | +34.94% |
| Shares Change (QoQ) | +4.47% |
| Owned by Insiders (%) | 0.91% |
| Owned by Institutions (%) | n/a |
| Float | 37.62M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.19 |
| PB Ratio | 0.51 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 17.93, with an EV/FCF ratio of -41.30.
| EV / Earnings | -2.25 |
| EV / Sales | 0.22 |
| EV / EBITDA | 17.93 |
| EV / EBIT | n/a |
| EV / FCF | -41.30 |
Financial Position
The company has a current ratio of 1.25, with a Debt / Equity ratio of 0.19.
| Current Ratio | 1.25 |
| Quick Ratio | 1.02 |
| Debt / Equity | 0.19 |
| Debt / EBITDA | 4.68 |
| Debt / FCF | -13.55 |
| Interest Coverage | -4.60 |
Financial Efficiency
Return on equity (ROE) is -20.02% and return on invested capital (ROIC) is -5.82%.
| Return on Equity (ROE) | -20.02% |
| Return on Assets (ROA) | -4.51% |
| Return on Capital (ROIC) | -5.82% |
| Revenue Per Employee | 3.85B |
| Profits Per Employee | -376.76M |
| Employee Count | 37 |
| Asset Turnover | 1.72 |
| Inventory Turnover | 26.58 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -49.52% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | -49.52% |
| 50-Day Moving Average | 495.14 |
| 200-Day Moving Average | 637.33 |
| Relative Strength Index (RSI) | 37.23 |
| Average Volume (20 Days) | 95,703 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Biolog Device had revenue of KRW 142.35 billion and -13.94 billion in losses. Loss per share was -244.59.
| Revenue | 142.35B |
| Gross Profit | 4.63B |
| Operating Income | -5.98B |
| Pretax Income | -8.95B |
| Net Income | -13.94B |
| EBITDA | 2.20B |
| EBIT | -5.98B |
| Loss Per Share | -244.59 |
Balance Sheet
The company has 6.58 billion in cash and 10.28 billion in debt, giving a net cash position of -3.70 billion or -56.16 per share.
| Cash & Cash Equivalents | 6.58B |
| Total Debt | 10.28B |
| Net Cash | -3.70B |
| Net Cash Per Share | -56.16 |
| Equity (Book Value) | 53.87B |
| Book Value Per Share | 910.73 |
| Working Capital | 7.16B |
Cash Flow
In the last 12 months, operating cash flow was 2.74 billion and capital expenditures -3.50 billion, giving a free cash flow of -758.74 million.
| Operating Cash Flow | 2.74B |
| Capital Expenditures | -3.50B |
| Free Cash Flow | -758.74M |
| FCF Per Share | -11.51 |
Margins
Gross margin is 3.25%, with operating and profit margins of -4.20% and -9.79%.
| Gross Margin | 3.25% |
| Operating Margin | -4.20% |
| Pretax Margin | -6.28% |
| Profit Margin | -9.79% |
| EBITDA Margin | 1.54% |
| EBIT Margin | -4.20% |
| FCF Margin | -0.53% |
Dividends & Yields
Biolog Device does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -34.94% |
| Shareholder Yield | -34.94% |
| Earnings Yield | -52.38% |
| FCF Yield | -2.47% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Biolog Device has an Altman Z-Score of 2.43. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.43 |
| Piotroski F-Score | n/a |